Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- Both men and women are eligible to participate
- People who have had a type of shoulder replacement surgery called Reverse Shoulder Arthroplasty or Shoulder Hemiarthroplasty, for any medically accepted reason
- People whose shoulder replacement surgery involved use of the Tipmed™ Shoulder Prosthesis System
- People who are not subject to legal restrictions on participation, such as active military personnel, people who are incarcerated, or people under legal guardianship
- People who have freely chosen to sign the required consent form agreeing to take part in the study
Who may not be able to join:
- People who are currently taking part in another clinical trial that involves a medical intervention
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Özgün Karakuş, Assoc. Prof., Republic of Turkey Ministry of Health Balıkesir Provincial Health Directorate, Atatürk City Hospital
Phone: +90 232 479 33 22
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Functional Capacity Assessment via Modified Constant-Murley Score (MCMS); Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs); Incidence of Clinical Complications
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.